← board
GLUC
$0.40+15%today-29% from 52w high
Revenue
pre-revenue
Liquidity
—
Runway
—
Shares 1y
—
Price & events
-10.2% over 6M
CatalystRating changeDilutionFinancingdashed = today
+14.8%
1D
+21.5%
1W
-14.9%
1M
+6.2%
3M
-10.2%
6M
+295.0%
1Y
-6.4%
2Y
-85.8%
5Y
-94.9%
All
Overview
- Market Cap
- $1.80M
- Volume
- 600
- 52 Week Range
- $0.02 – $0.56
- Total Shares
- 4.55M
- Float Shares
- 8.27M
- % Held by Insiders
- 5.10%
- % Held by Institutions
- 0.00%
- RVOL
- 0.09x
- Beta
- 1.03
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 4,545,310
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.